Manos Perros is the founder of Entasis Therapeutics. Entasis Therapeutics has raised $122M in total funding. Latest round: Series B. Based in Waltham, MA.
Manos Perros is the CEO of Entasis Therapeutics, a late-stage antibiotic biotech founded in 2015 as a spinout from AstraZeneca to treat drug-resistant bacterial infections. He led the company through several funding rounds before its acquisition by Innoviva in 2022.
Full founder directory · Investor directory · Company funding database · Fundraising library